Edmund J. Elder

464 total citations
8 papers, 361 citations indexed

About

Edmund J. Elder is a scholar working on Pharmaceutical Science, Materials Chemistry and Molecular Biology. According to data from OpenAlex, Edmund J. Elder has authored 8 papers receiving a total of 361 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Pharmaceutical Science, 3 papers in Materials Chemistry and 2 papers in Molecular Biology. Recurrent topics in Edmund J. Elder's work include Drug Solubulity and Delivery Systems (4 papers), Crystallization and Solubility Studies (3 papers) and Pharmaceutical Economics and Policy (2 papers). Edmund J. Elder is often cited by papers focused on Drug Solubulity and Delivery Systems (4 papers), Crystallization and Solubility Studies (3 papers) and Pharmaceutical Economics and Policy (2 papers). Edmund J. Elder collaborates with scholars based in United States and India. Edmund J. Elder's co-authors include True L. Rogers, Keith P. Johnston, Blair Brettmann, Michal E. Matteucci, Robert O. Williams, Michael Privitera, Jerzy P. Szaflarski, John R. Pollard, Xiaohui Jiang and Michel J. Berg and has published in prestigious journals such as The Lancet Neurology, Pharmaceutical Research and JAMA Neurology.

In The Last Decade

Edmund J. Elder

8 papers receiving 331 citations

Peers

Edmund J. Elder

PS

PPCH

EE

MC

PMH

Mario Maio Germany

Mary P. Stickelmeyer United States

David Cheng Thiam Tan United States

Biplob Mitra United States

Jens Van Den Αbeele Belgium

Patrick Sterkens Belgium

Charles H. Becker United States

Umesh V. Banakar United States

Johannes Krämer Germany

H. Möller Germany

Mario Maio Germany

Edmund J. Elder

468 ×2.5

PS

102 ×1.1

PPCH

26 ×0.4

EE

142 ×2.0

MC

13 ×0.3

PMH

Citations per year, relative to Edmund J. Elder Edmund J. Elder (= 1×) peers Mario Maio

Countries citing papers authored by Edmund J. Elder

Since Specialization

Citations

This map shows the geographic impact of Edmund J. Elder's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Edmund J. Elder with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Edmund J. Elder more than expected).

Fields of papers citing papers by Edmund J. Elder

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Edmund J. Elder. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Edmund J. Elder. The network helps show where Edmund J. Elder may publish in the future.

Co-authorship network of co-authors of Edmund J. Elder

This figure shows the co-authorship network connecting the top 25 collaborators of Edmund J. Elder. A scholar is included among the top collaborators of Edmund J. Elder based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Edmund J. Elder. Edmund J. Elder is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

1.

Sacchetti, Mark, et al.. (2017). Role of Water Sorption in Tablet Crushing Strength, Disintegration, and Dissolution. AAPS PharmSciTech. 18(6). 2214–2226. 16 indexed citations

2.

Berg, Michel J., Timothy E. Welty, Barry E. Gidal, et al.. (2017). Bioequivalence Between Generic and Branded Lamotrigine in People With Epilepsy. JAMA Neurology. 74(8). 919–919. 37 indexed citations

3.

Privitera, Michael, Timothy E. Welty, Barry E. Gidal, et al.. (2016). Generic-to-generic lamotrigine switches in people with epilepsy: the randomised controlled EQUIGEN trial. The Lancet Neurology. 15(4). 365–372. 73 indexed citations

4.

Schwan, William R., Jill Kolesar, Md. Tanvir Kabir, et al.. (2015). Pharmacokinetic/Toxicity Properties of the New Anti-Staphylococcal Lead Compound SK-03-92. Antibiotics. 4(4). 617–626. 2 indexed citations

5.

Schulz, Lucas, et al.. (2010). Stability of Sodium Nitroprusside and Sodium Thiosulfate 1:10 Intravenous Admixture. Hospital Pharmacy. 45(10). 779–784. 4 indexed citations

6.

Elder, Edmund J., et al.. (2007). Preparation, Characterization, and Scale-up of Ketoconazole with Enhanced Dissolution and Bioavailability. Drug Development and Industrial Pharmacy. 33(7). 755–765. 14 indexed citations

7.

Matteucci, Michal E., Blair Brettmann, True L. Rogers, et al.. (2007). Design of Potent Amorphous Drug Nanoparticles for Rapid Generation of Highly Supersaturated Media. Molecular Pharmaceutics. 4(5). 782–793. 139 indexed citations

8.

Rogers, True L., et al.. (2004). Development and Characterization of a Scalable Controlled Precipitation Process to Enhance the Dissolution of Poorly Water-Soluble Drugs. Pharmaceutical Research. 21(11). 2048–2057. 76 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact